ADVI Health’s senior advisor, Norris Turner, PharmD, PhD, will be attending the AMCP Foundation Research Symposium, which will be taking place in Dallas, TX, on December 3-4.
While there, Norris will moderate a panel titled “Addressing Disparities in the Evidence-Based Use of Biomarker-Driven Precision Oncology,” which will take place on Wednesday, December 4 from 8:30 am-9:15 am. The panel will expand on how access to and receipt of appropriate biomarker testing must be an attainable goal to ensure equal access to quality care. Joining him will be esteemed panelists Ira Klein, MD, MBA, and Lalan Wilfong, MD, for what promises to be a powerful conversation shaping the future of precision oncology.
Get in touch and learn more.
